Abortion rights supporters say ruling is most sweeping threat to access since supreme court overturned Roe in 2022 Access to mifepristone, the FDA-approved medication used to end pregnancy, could become severely limited following a ruling from a US appeals court on Friday, which temporarily blocked the drug from being dispensed through the mail. The decision is for now the most sweeping threat to abortion access since the supreme court rolled back abortion rights in 2022, said Kelly Baden, vice-president at the Guttmacher Institute, an abortion rights advocacy group. Continue reading...

AI summaries can be wrong sometimes—always verify important details using the source article.